Old Web
English
Sign In
Acemap
>
Paper
>
MA05.07 Efficacy and Safety of Re-Treatment with Tremelimumab and Durvalumab Within the NIBIT-MESO-1 Study
MA05.07 Efficacy and Safety of Re-Treatment with Tremelimumab and Durvalumab Within the NIBIT-MESO-1 Study
2019
Luana Calabrò
G. C Rossi
Aldo Morra
A.M. Di Giacomo
Giovanni Amato
C. Rosati
Ornella Cutaia
M.G. Daffinà
Diana Giannarelli
Michele Maio
Keywords:
Tremelimumab
Oncology
General surgery
Durvalumab
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]